124 related articles for article (PubMed ID: 26437123)
1. Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment.
Knopman DS; Jack CR; Lundt ES; Wiste HJ; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Machulda MM; Roberts RO; Boeve BF; Jones DT; Petersen RC
JAMA Neurol; 2015 Dec; 72(12):1475-83. PubMed ID: 26437123
[TBL] [Abstract][Full Text] [Related]
2. Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum.
Knopman DS; Jack CR; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Machulda MM; Roberts RO; Boeve BF; Jones DT; Petersen RC
Neurobiol Aging; 2016 Oct; 46():32-42. PubMed ID: 27460147
[TBL] [Abstract][Full Text] [Related]
3. Association of Initial β-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment.
Knopman DS; Lundt ES; Therneau TM; Albertson SM; Gunter JL; Senjem ML; Schwarz CG; Mielke MM; Machulda MM; Boeve BF; Jones DT; Graff-Radford J; Vemuri P; Kantarci K; Lowe VJ; Petersen RC; Jack CR;
JAMA Neurol; 2021 Feb; 78(2):217-228. PubMed ID: 33074304
[TBL] [Abstract][Full Text] [Related]
4. Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study.
Jack CR; Wiste HJ; Weigand SD; Rocca WA; Knopman DS; Mielke MM; Lowe VJ; Senjem ML; Gunter JL; Preboske GM; Pankratz VS; Vemuri P; Petersen RC
Lancet Neurol; 2014 Oct; 13(10):997-1005. PubMed ID: 25201514
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome.
Lao PJ; Handen BL; Betthauser TJ; Mihaila I; Hartley SL; Cohen AD; Tudorascu DL; Bulova PD; Lopresti BJ; Tumuluru RV; Murali D; Mathis CA; Barnhart TE; Stone CK; Price JC; Devenny DA; Johnson SC; Klunk WE; Christian BT
J Alzheimers Dis; 2018; 61(2):631-644. PubMed ID: 29254096
[TBL] [Abstract][Full Text] [Related]
6. Mapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects.
Araque Caballero MÁ; Brendel M; Delker A; Ren J; Rominger A; Bartenstein P; Dichgans M; Weiner MW; Ewers M;
Neurobiol Aging; 2015 Nov; 36(11):2913-2924. PubMed ID: 26476234
[TBL] [Abstract][Full Text] [Related]
7. Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease.
Shirzadi Z; Schultz SA; Yau WW; Joseph-Mathurin N; Fitzpatrick CD; Levin R; Kantarci K; Preboske GM; Jack CR; Farlow MR; Hassenstab J; Jucker M; Morris JC; Xiong C; Karch CM; Levey AI; Gordon BA; Schofield PR; Salloway SP; Perrin RJ; McDade E; Levin J; Cruchaga C; Allegri RF; Fox NC; Goate A; Day GS; Koeppe R; Chui HC; Berman S; Mori H; Sanchez-Valle R; Lee JH; Rosa-Neto P; Ruthirakuhan M; Wu CY; Swardfager W; Benzinger TLS; Sohrabi HR; Martins RN; Bateman RJ; Johnson KA; Sperling RA; Greenberg SM; Schultz AP; Chhatwal JP;
JAMA Neurol; 2023 Dec; 80(12):1353-1363. PubMed ID: 37843849
[TBL] [Abstract][Full Text] [Related]
8. Patterns of Glucose Metabolism in [
Lee JJ; Earnest T; Ha SM; Bani A; Kothapalli D; Liu P; Sotiras A
medRxiv; 2023 Nov; ():. PubMed ID: 38116031
[TBL] [Abstract][Full Text] [Related]
9. Cerebral Amyloid Deposition Is Associated with Gait Parameters in the Mayo Clinic Study of Aging.
Wennberg AMV; Savica R; Hagen CE; Roberts RO; Knopman DS; Hollman JH; Vemuri P; Jack CR; Petersen RC; Mielke MM
J Am Geriatr Soc; 2017 Apr; 65(4):792-799. PubMed ID: 27869301
[TBL] [Abstract][Full Text] [Related]
10. Relative equilibrium plot improves graphical analysis and allows bias correction of standardized uptake value ratio in quantitative 11C-PiB PET studies.
Zhou Y; Sojkova J; Resnick SM; Wong DF
J Nucl Med; 2012 Apr; 53(4):622-8. PubMed ID: 22414634
[TBL] [Abstract][Full Text] [Related]
11. Cerebral Metabolic Signature of Chronic Benzodiazepine Use in Nondemented Older Adults: An FDG-PET Study in the MEMENTO Cohort.
Gallet Q; Bouteloup V; Locatelli M; Habert MO; Chupin M; Campion JY; Michels PE; Delrieu J; Lebouvier T; Balageas AC; Surget A; Belzung C; Arlicot N; Ribeiro MS; Gissot V; El-Hage W; Camus V; Gohier B; Desmidt T;
Am J Geriatr Psychiatry; 2024 Jun; 32(6):665-677. PubMed ID: 37973486
[TBL] [Abstract][Full Text] [Related]
12. Cortical Microstructural Alterations in Mild Cognitive Impairment and Alzheimer's Disease Dementia.
Vogt NM; Hunt JF; Adluru N; Dean DC; Johnson SC; Asthana S; Yu JJ; Alexander AL; Bendlin BB
Cereb Cortex; 2020 May; 30(5):2948-2960. PubMed ID: 31833550
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Amyloid Protective Factors and Alzheimer Disease Neurodegeneration Protective Factors in Elderly Individuals.
Vemuri P; Knopman DS; Lesnick TG; Przybelski SA; Mielke MM; Graff-Radford J; Murray ME; Roberts RO; Vassilaki M; Lowe VJ; Machulda MM; Jones DT; Petersen RC; Jack CR
JAMA Neurol; 2017 Jun; 74(6):718-726. PubMed ID: 28418521
[TBL] [Abstract][Full Text] [Related]
14. Higher homocysteine associated with thinner cortical gray matter in 803 participants from the Alzheimer's Disease Neuroimaging Initiative.
Madsen SK; Rajagopalan P; Joshi SH; Toga AW; Thompson PM;
Neurobiol Aging; 2015 Jan; 36 Suppl 1():S203-10. PubMed ID: 25444607
[TBL] [Abstract][Full Text] [Related]
15. Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease.
Raghavan NS; Dumitrescu L; Mormino E; Mahoney ER; Lee AJ; Gao Y; Bilgel M; Goldstein D; Harrison T; Engelman CD; Saykin AJ; Whelan CD; Liu JZ; Jagust W; Albert M; Johnson SC; Yang HS; Johnson K; Aisen P; Resnick SM; Sperling R; De Jager PL; Schneider J; Bennett DA; Schrag M; Vardarajan B; Hohman TJ; Mayeux R;
JAMA Neurol; 2020 Oct; 77(10):1288-1298. PubMed ID: 32568366
[TBL] [Abstract][Full Text] [Related]
16. A graph theoretic approach to neurodegeneration: five data-driven neuropsychological subtypes in mild cognitive impairment.
Pommy J; Conant L; Butts AM; Nencka A; Wang Y; Franczak M; Glass-Umfleet L
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2023; 30(6):903-922. PubMed ID: 36648118
[TBL] [Abstract][Full Text] [Related]
17. Baseline Frontoparietal Gray Matter Volume Predicts Executive Function Performance in Aging and Mild Cognitive Impairment at 24-Month Follow-Up.
Lee AJ; Stark JH; Hayes SM;
J Alzheimers Dis; 2024 Jun; ():. PubMed ID: 38875035
[TBL] [Abstract][Full Text] [Related]
18. Relationship between Neuroimaging and Cognition in Frontotemporal Dementia: A [18 F]FDG PET and Structural MRI Study.
Cayir S; Volpi T; Toyonaga T; Gallezot JD; Yanghong Y; Sadabad FE; Mulnix T; Mecca AP; Fesharaki-Zadeh A; Matuskey D
Res Sq; 2024 Jan; ():. PubMed ID: 38313264
[TBL] [Abstract][Full Text] [Related]
19. A multimodal clinical diagnostic approach using MRI and
Lavrova A; Pham NTT; Vernon CJ; Carlos AF; Petersen RC; Dickson DW; Lowe VJ; Jack CR; Whitwell JL; Josephs KA
J Neurol; 2024 Apr; ():. PubMed ID: 38578498
[TBL] [Abstract][Full Text] [Related]
20. Relationships among Cortical Glutathione Levels, Brain Amyloidosis, and Memory in Healthy Older Adults Investigated In Vivo with
Chiang GC; Mao X; Kang G; Chang E; Pandya S; Vallabhajosula S; Isaacson R; Ravdin LD; ; Shungu DC
AJNR Am J Neuroradiol; 2017 Jun; 38(6):1130-1137. PubMed ID: 28341718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
